Author:
Boor Patrick P.C.,de Ruiter Petra E.,Asmawidjaja Patrick S.,Lubberts Erik,van der Laan Luc J.W.,Kwekkeboom Jaap
Subject
Biochemistry (medical),Public Health, Environmental and Occupational Health,General Medicine,Physiology (medical)
Reference63 articles.
1. Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis;Fleischmann;N Engl J Med,2012
2. Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550);Ghoreschi;J Immunol,2011
3. A phase 2 study of tofacitinib, an oral Janus kinase inhibitor, in patients with Crohn's disease;Sandborn;Clin Gastroenterol Hepatol,2014
4. Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis;Sandborn;N Engl J Med,2012
5. Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial;Bachelez;Lancet,2015
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献